isoeugenol has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, PW; Hao, CL; Lin, HL; Shen, KP; Tu, YC; Wu, BN; Yeh, BC | 1 |
| Rauscher, FM; Sanders, RA; Watkins, JB | 1 |
2 other study(ies) available for isoeugenol and Alloxan Diabetes
| Article | Year |
|---|---|
Efficiency comparison of an isoeugenol-derivated compound, eugenosedin-A, with glibenclamide and pioglitazone in protecting cardiovascular dysfunction of diabetic SHR.
Topics: Animals; Diabetes Mellitus, Experimental; Glyburide; Hypoglycemic Agents; Pioglitazone; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley | 2023 |
Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Brain; Catalase; Diabetes Mellitus, Experimental; Eugenol; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Kidney; Liver; Molecular Structure; Myocardium; Oxidative Stress; Rats; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2001 |